Exagen Inc. Reports Strong Q3 2025 Results

2 months ago

CARLSBAD, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today…

Jasper Therapeutics to Present at Upcoming Investor Conferences

2 months ago

REDWOOD CITY, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company…

Certara Automates Scientific Workflows with Phoenix® Cloud

2 months ago

New cloud capabilities cut time to create Tables, Figures, and Listings by 50%RADNOR, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) --…

Erasca to Present at Upcoming Conferences in November

2 months ago

SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on…

UroGen Pharma to Present at Guggenheim Securities Healthcare Innovation Conference

2 months ago

PRINCETON, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and…

ORYZON Announces Positive Clinical Data of Iadademstat at ASH-2025

2 months ago

Three iadademstat abstracts have been accepted for presentation at the upcoming ASH-2025 Annual MeetingPreliminary data from the ongoing Phase Ib…

Akebia Therapeutics to Present at Upcoming Investor Conferences

2 months ago

CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to…

Kestra Medical Technologies to Present Late-Breaking ACE-PAS Trial Results at AHA 2025, Showcasing Next-Generation Wearable Defibrillator System

2 months ago

KIRKLAND, Wash., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital…

Mercury Dental Fillings Raise Blood Mercury to Dangerous Levels in 100+ Million Americans

2 months ago

Dr. Griffin Cole of the IAOMT discussing the study findings of elevated levels of mercury from amalgam dental fillings in…

Dianthus Therapeutics to Participate in Four Investor Conferences During November

2 months ago

NEW YORK and WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company…